Agree @ddwn,
Its obvious many holders are/were selling off forthcoming allocated shares above the CR price of .30c for a quick profit - as SI said at the AGM, funding was not going to be a problem he and his team need to get the 1st Remestemcal-L platform {steroid refractory acute graft versus host disease approved by the FDA.
As reported, no industrially manufactured, non-hematopoietic cell products have been approved in the US, so once we get this one over the line the SP will reflect the massive potential of what should be that paradigm shift in medical treatment.
ST
Agree @ddwn,Its obvious many holders are/were selling off...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 59978 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 34019 | 3 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.070 ( 5.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3733217 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |